mitomycin has been researched along with Cystitis in 29 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Cystitis: Inflammation of the URINARY BLADDER, either from bacterial or non-bacterial causes. Cystitis is usually associated with painful urination (dysuria), increased frequency, urgency, and suprapubic pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We performed a meta-analysis to evaluate the effect of intravesical mitomycin compared with gemcitabine on the treatment of non-muscle invasive bladder cancer." | 9.41 | Effect of intravesical mitomycin compared with gemcitabine on the treatment non-muscle invasive bladder cancer: A meta-analysis. ( Cheng, W; Chu, X; Huang, S; Zheng, H; Zheng, X; Zhou, Y, 2023) |
| "We compared intravesical instillations with mitomycin-C (MMC), Bacillus Calmette-Guerin (BCG) Tice, and BCG-RIVM in patients with pTa-pT1 papillary carcinoma and primary carcinoma in situ (CIS) of the bladder." | 9.07 | A randomised prospective study comparing intravesical instillations of mitomycin-C, BCG-Tice, and BCG-RIVM in pTa-pT1 tumours and primary carcinoma in situ of the urinary bladder. Dutch South-East Cooperative Urological Group. ( Debruyne, FM; Doesburg, W; Schaafsma, HE; vd Meijden, AP; Witjes, JA; Witjes, WP, 1993) |
| "Intravesical chemotherapy involving the sequential instillation of mitomycin C (MMC) and Adriamycin (ADM) was performed in 40 patients with superficial bladder cancer (pathological stages Ta and T1)." | 9.07 | Sequential instillation therapy with mitomycin C and adriamycin for superficial bladder cancer. ( Abe, K; Isaka, S; Okano, T; Shimazaki, J, 1992) |
| "Bladder retraction is a rare complication of contact chemotherapy with mitomycin C in the treatment of superficial bladder cancer." | 8.79 | [Bladder retraction, a complication of chemoprophylaxis of superficial bladder cancer using intravesical mitomycin C. Apropos of a case and review of the literature]. ( Hubert, J; Mangin, P; Punga-Maole, ML, 1995) |
| "Bladder wall calcification is a rare complication of intravesical therapy of superficial bladder cancer with Mitomycin C." | 7.68 | Incrusted cystitis after intravesical mitomycin C treatment. ( Algado, M; Botella, R; Llopis, M; Moreno, J, 1993) |
| "We analyzed 29 cases of eosinophilic cystitis in a group of 80 patients with lower urothelial carcinoma who had been treated with mitomycin-C." | 7.68 | [Eosinophilic cystitis as a special form of response to mitomycin C. Analysis and comments on our cases]. ( Arango Toro, O; Bielsa Galí, O; Corominas, J; Gelabert Mas, A; Lladó Carbonell, C; Vesa Llanes, J, 1991) |
| "During long periods of buffered instillations of mitomycin C (MMC) and doxorubicin (adriamycin; ADM) on carcinoma in situ (TIS), the complete response was 82% for MMC and 80% for ADM." | 7.67 | Effect of mitomycin C and doxorubicin instillation on carcinoma in situ of the urinary bladder. A Finnish multicenter study. ( Alfthan, O; Jauhiainen, K; Permi, J; Sotarauta, M, 1986) |
| "Twenty-three patients with histologically proven superficial bladder cancer (Tis, Ta, T1) were treated with intravesical instillations of Mitomycin C at a dose of 20 mg in 20 ml of water 3 times weekly for 21 instillations." | 7.66 | A phase II study of intravesical mitomycin C in the treatment of superficial bladder cancer. ( Green, DF; Harrison, GS; Newling, DW; Richards, B; Robinson, MR; Smith, PH, 1983) |
| "We performed a meta-analysis to evaluate the effect of intravesical mitomycin compared with gemcitabine on the treatment of non-muscle invasive bladder cancer." | 5.41 | Effect of intravesical mitomycin compared with gemcitabine on the treatment non-muscle invasive bladder cancer: A meta-analysis. ( Cheng, W; Chu, X; Huang, S; Zheng, H; Zheng, X; Zhou, Y, 2023) |
| "Mitomycin C (MMC) is a widely used agent for the adjuvant treatment of bladder tumors." | 5.35 | Perivesical inflammation and necrosis due to mitomycin C instillation after transurethral resection of bladder tumor: we must be vigilant! ( Cek, M; Fazlioglu, A; Kurtulus, FO; Parlakkilic, O; Tandogdu, Z, 2009) |
| "Eosinophilic cystitis is an unusual form of cystitis which is characterized by irritative voiding symptoms and haematuria." | 5.29 | Eosinophilic cystitis induced by mitomycin-C. ( Apaydin, E; Gürsan, A; Kandiloğlu, G; Ozyurt, C; Ulker, V, 1996) |
| "We compared intravesical instillations with mitomycin-C (MMC), Bacillus Calmette-Guerin (BCG) Tice, and BCG-RIVM in patients with pTa-pT1 papillary carcinoma and primary carcinoma in situ (CIS) of the bladder." | 5.07 | A randomised prospective study comparing intravesical instillations of mitomycin-C, BCG-Tice, and BCG-RIVM in pTa-pT1 tumours and primary carcinoma in situ of the urinary bladder. Dutch South-East Cooperative Urological Group. ( Debruyne, FM; Doesburg, W; Schaafsma, HE; vd Meijden, AP; Witjes, JA; Witjes, WP, 1993) |
| "Intravesical chemotherapy involving the sequential instillation of mitomycin C (MMC) and Adriamycin (ADM) was performed in 40 patients with superficial bladder cancer (pathological stages Ta and T1)." | 5.07 | Sequential instillation therapy with mitomycin C and adriamycin for superficial bladder cancer. ( Abe, K; Isaka, S; Okano, T; Shimazaki, J, 1992) |
| "Bladder retraction is a rare complication of contact chemotherapy with mitomycin C in the treatment of superficial bladder cancer." | 4.79 | [Bladder retraction, a complication of chemoprophylaxis of superficial bladder cancer using intravesical mitomycin C. Apropos of a case and review of the literature]. ( Hubert, J; Mangin, P; Punga-Maole, ML, 1995) |
| "Bladder wall calcification is a rare complication of intravesical therapy of superficial bladder cancer with Mitomycin C." | 3.68 | Incrusted cystitis after intravesical mitomycin C treatment. ( Algado, M; Botella, R; Llopis, M; Moreno, J, 1993) |
| "We analyzed 29 cases of eosinophilic cystitis in a group of 80 patients with lower urothelial carcinoma who had been treated with mitomycin-C." | 3.68 | [Eosinophilic cystitis as a special form of response to mitomycin C. Analysis and comments on our cases]. ( Arango Toro, O; Bielsa Galí, O; Corominas, J; Gelabert Mas, A; Lladó Carbonell, C; Vesa Llanes, J, 1991) |
| "During long periods of buffered instillations of mitomycin C (MMC) and doxorubicin (adriamycin; ADM) on carcinoma in situ (TIS), the complete response was 82% for MMC and 80% for ADM." | 3.67 | Effect of mitomycin C and doxorubicin instillation on carcinoma in situ of the urinary bladder. A Finnish multicenter study. ( Alfthan, O; Jauhiainen, K; Permi, J; Sotarauta, M, 1986) |
| "Three cases are presented in which eosinophilic cystitis developed when patients who were known to have superficial bladder cancer were treated with instillations of the alkylating agent Mitomycin C." | 3.67 | Allergy to mitomycin C complicating topical administration for urothelial cancer. ( Grigor, KM; Inglis, JA; Tolley, DA, 1987) |
| "Intravesical chemotherapy with sequential instillation of mitomycin C and adriamycin was carried out on 19 patients with superficial bladder cancer (Ta, T1 and Tis)." | 3.67 | [Sequential intravesical chemotherapy with mitomycin C and adriamycin for superficial bladder tumor (preliminary report)]. ( Fukui, I; Kihara, K; Sekine, H; Yamada, T, 1985) |
| "Twenty-three patients with histologically proven superficial bladder cancer (Tis, Ta, T1) were treated with intravesical instillations of Mitomycin C at a dose of 20 mg in 20 ml of water 3 times weekly for 21 instillations." | 3.66 | A phase II study of intravesical mitomycin C in the treatment of superficial bladder cancer. ( Green, DF; Harrison, GS; Newling, DW; Richards, B; Robinson, MR; Smith, PH, 1983) |
| "After ligation of ureters and urethra, male Sprague-Dawley rats were treated over 3 h with either 2 mg mitomycin C (MMC) intravesically (group I), or in conjunction with pre-instillation bladder electrocoagulation (group II) or iatrogenic Escherichia coli/xylene-induced severe cystitis (group III)." | 3.66 | Experimental investigations on the absorption of intravesically instilled mitomycin C in the urinary bladder of the rat. ( Bürger, R; Engelmann, U; Jacobi, GH, 1982) |
| "Mitomycin C (MMC) is a widely used agent for the adjuvant treatment of bladder tumors." | 1.35 | Perivesical inflammation and necrosis due to mitomycin C instillation after transurethral resection of bladder tumor: we must be vigilant! ( Cek, M; Fazlioglu, A; Kurtulus, FO; Parlakkilic, O; Tandogdu, Z, 2009) |
| "Eosinophilic cystitis is an unusual form of cystitis which is characterized by irritative voiding symptoms and haematuria." | 1.29 | Eosinophilic cystitis induced by mitomycin-C. ( Apaydin, E; Gürsan, A; Kandiloğlu, G; Ozyurt, C; Ulker, V, 1996) |
| "Mitomycin C is an alkylating agent, used by intravesical instillation to treat carcinoma of the bladder." | 1.28 | Dermatitis due to intravesical mitomycin C: a delayed-type hypersensitivity reaction? ( Colver, GB; Hunter, JA; Inglis, JA; McVittie, E; Spencer, MJ; Tolley, DA, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (41.38) | 18.7374 |
| 1990's | 9 (31.03) | 18.2507 |
| 2000's | 4 (13.79) | 29.6817 |
| 2010's | 3 (10.34) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, W | 1 |
| Zhou, Y | 1 |
| Chu, X | 1 |
| Huang, S | 1 |
| Zheng, X | 1 |
| Zheng, H | 1 |
| Cameo, MI | 1 |
| Lezcano, MA | 1 |
| Gil, D | 1 |
| Blas, M | 1 |
| Fazlioglu, A | 1 |
| Tandogdu, Z | 1 |
| Kurtulus, FO | 1 |
| Parlakkilic, O | 1 |
| Cek, M | 1 |
| Caso, J | 1 |
| Qin, D | 1 |
| Sexton, WJ | 1 |
| Wolff, HA | 1 |
| Raus, I | 1 |
| Jung, K | 1 |
| Schüler, P | 1 |
| Herrmann, MK | 1 |
| Hennies, S | 1 |
| Vorwerk, H | 1 |
| Hille, A | 1 |
| Hess, CF | 1 |
| Christiansen, H | 1 |
| Böhle, A | 1 |
| Jocham, D | 1 |
| Bock, PR | 1 |
| Joselson, R | 1 |
| Warnock, M | 1 |
| Engelmann, U | 2 |
| Oelsner, G | 1 |
| Bürger, RA | 1 |
| Wagner, H | 1 |
| Niijima, T | 1 |
| Koiso, K | 1 |
| Akaza, H | 1 |
| Harrison, GS | 1 |
| Green, DF | 1 |
| Newling, DW | 1 |
| Richards, B | 1 |
| Robinson, MR | 1 |
| Smith, PH | 1 |
| Schmidbauer, CP | 1 |
| Porpaczy, P | 1 |
| Georgopoulos, A | 1 |
| Rameis, H | 1 |
| Erdmann, WD | 1 |
| Harzmann, R | 1 |
| Flüchter, SH | 1 |
| Bichler, KH | 1 |
| Bürger, R | 1 |
| Jacobi, GH | 1 |
| Punga-Maole, ML | 1 |
| Hubert, J | 1 |
| Mangin, P | 1 |
| Llopis, M | 1 |
| Moreno, J | 1 |
| Botella, R | 1 |
| Algado, M | 1 |
| Witjes, JA | 1 |
| vd Meijden, AP | 1 |
| Witjes, WP | 1 |
| Doesburg, W | 2 |
| Schaafsma, HE | 1 |
| Debruyne, FM | 2 |
| Ulker, V | 1 |
| Apaydin, E | 1 |
| Gürsan, A | 1 |
| Ozyurt, C | 1 |
| Kandiloğlu, G | 1 |
| Cliff, AM | 1 |
| Romaniuk, CS | 1 |
| Parr, NJ | 1 |
| Clark, T | 1 |
| Chang, SS | 1 |
| Cookson, MS | 1 |
| Isaka, S | 1 |
| Okano, T | 1 |
| Abe, K | 1 |
| Shimazaki, J | 1 |
| Gelabert Mas, A | 2 |
| Vesa Llanes, J | 1 |
| Corominas, J | 1 |
| Arango Toro, O | 1 |
| Bielsa Galí, O | 1 |
| Lladó Carbonell, C | 1 |
| Dore, B | 1 |
| Aubert, J | 1 |
| Arango, O | 1 |
| Rosales, A | 1 |
| Coronado, J | 1 |
| Moreno, A | 1 |
| Colver, GB | 1 |
| Inglis, JA | 2 |
| McVittie, E | 1 |
| Spencer, MJ | 1 |
| Tolley, DA | 3 |
| Hunter, JA | 1 |
| van der Meijden, PM | 1 |
| Steerenberg, PA | 1 |
| de Jong, WH | 1 |
| Jauhiainen, K | 1 |
| Sotarauta, M | 1 |
| Permi, J | 1 |
| Alfthan, O | 1 |
| Grigor, KM | 1 |
| MacFarlane, JR | 1 |
| Fukui, I | 1 |
| Sekine, H | 1 |
| Yamada, T | 1 |
| Kihara, K | 1 |
4 reviews available for mitomycin and Cystitis
| Article | Year |
|---|---|
Effect of intravesical mitomycin compared with gemcitabine on the treatment non-muscle invasive bladder cancer: A meta-analysis.
Topics: Administration, Intravesical; Cystitis; Deoxycytidine; Gemcitabine; Hematuria; Humans; Mitomycin; No | 2023 |
Eosinophilic cystitis following immediate post-resection intravesical instillation of mitomycin-C.
Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Cystitis; Eosinophilia; Female; Humans; M | 2010 |
Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity.
Topics: Adjuvants, Immunologic; Administration, Intravesical; Antibiotics, Antineoplastic; BCG Vaccine; Cyst | 2003 |
[Bladder retraction, a complication of chemoprophylaxis of superficial bladder cancer using intravesical mitomycin C. Apropos of a case and review of the literature].
Topics: Administration, Intravesical; Aged; Chemoprevention; Cystitis; Humans; Male; Mitomycin; Urinary Blad | 1995 |
4 trials available for mitomycin and Cystitis
| Article | Year |
|---|---|
Randomized clinical trial on chemoprophylaxis of recurrence in cases of superficial bladder cancer.
Topics: Clinical Trials as Topic; Cystitis; Doxorubicin; Humans; Japan; Mitomycin; Mitomycins; Neoplasm Recu | 1983 |
A randomised prospective study comparing intravesical instillations of mitomycin-C, BCG-Tice, and BCG-RIVM in pTa-pT1 tumours and primary carcinoma in situ of the urinary bladder. Dutch South-East Cooperative Urological Group.
Topics: Administration, Intravesical; Aged; BCG Vaccine; Carcinoma in Situ; Carcinoma, Transitional Cell; Cy | 1993 |
Sequential instillation therapy with mitomycin C and adriamycin for superficial bladder cancer.
Topics: Administration, Intravesical; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cystitis; | 1992 |
BCG-RIVM versus BCG-Tice versus mitomycin-C in superficial bladder cancer. Rationale and design of the trial of the Southeast Co-operative Urological Group, The Netherlands.
Topics: Administration, Intravesical; BCG Vaccine; Carcinoma in Situ; Carcinoma, Papillary; Cystitis; Humans | 1989 |
21 other studies available for mitomycin and Cystitis
| Article | Year |
|---|---|
[Urinary tuberculosis caused by Mycobacterium bovis BCG variety, following intravesical instillation].
Topics: Administration, Intravesical; Aged; Antitubercular Agents; BCG Vaccine; Carcinoma, Transitional Cell | 2010 |
Perivesical inflammation and necrosis due to mitomycin C instillation after transurethral resection of bladder tumor: we must be vigilant!
Topics: Administration, Intravesical; Aged; Anti-Bacterial Agents; Cystectomy; Cystitis; Humans; Male; Mitom | 2009 |
High-grade acute organ toxicity as a positive prognostic factor in primary radiochemotherapy for anal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols | 2011 |
Pulmonary veno-occlusive disease after chemotherapy.
Topics: Adult; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Cystitis; Female; Humans; Lung; Mitomycin; Mi | 1983 |
Permeability of the rat bladder to Cisplatinum under different conditions: comparison with Mitomycin C and Adriamycin.
Topics: Animals; Antibiotics, Antineoplastic; Cisplatin; Cystitis; Doxorubicin; Electrocoagulation; Mitomyci | 1983 |
A phase II study of intravesical mitomycin C in the treatment of superficial bladder cancer.
Topics: Carcinoma in Situ; Carcinoma, Transitional Cell; Cystitis; Drug Evaluation; Drug Implants; Erythema; | 1983 |
Absorption of doxorubicin-hydrochloride and mitomycin-C after instillation into noninfected and infected bladders of dogs.
Topics: Animals; Bacteriuria; Cystitis; Dogs; Doxorubicin; Male; Mitomycin; Mitomycins; Staphylococcal Infec | 1984 |
[Local mitomycin-C therapy of infiltrating bladder cancer].
Topics: Administration, Topical; Combined Modality Therapy; Cystitis; Humans; Mitomycin; Mitomycins; Neoplas | 1984 |
Experimental investigations on the absorption of intravesically instilled mitomycin C in the urinary bladder of the rat.
Topics: Absorption; Animals; Cystitis; Electrocoagulation; Escherichia coli Infections; Male; Mitomycin; Mit | 1982 |
Incrusted cystitis after intravesical mitomycin C treatment.
Topics: Administration, Intravesical; Calcinosis; Carcinoma, Transitional Cell; Combined Modality Therapy; C | 1993 |
Eosinophilic cystitis induced by mitomycin-C.
Topics: Administration, Intravesical; Biopsy; Carcinoma, Transitional Cell; Cystitis; Eosinophilia; Female; | 1996 |
Perivesical inflammation after early mitomycin C instillation.
Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Cystitis; Humans; Male; Middle Aged; Mito | 2000 |
Eosinophilic cystitis presenting as a recurrent symptomatic bladder mass following intravesical mitomycin C therapy.
Topics: Administration, Intravesical; Antibiotics, Antineoplastic; Cystitis; Eosinophilia; Humans; Male; Mid | 2002 |
[Eosinophilic cystitis as a special form of response to mitomycin C. Analysis and comments on our cases].
Topics: Administration, Intravesical; Antigen-Antibody Complex; Carcinoma; Combined Modality Therapy; Cystit | 1991 |
Re: Bladder wall calcification after intravesical mitomycin C treatment of superficial bladder cancer.
Topics: Administration, Intravesical; Calcinosis; Cystitis; Humans; Mitomycin; Mitomycins; Urinary Bladder N | 1991 |
Eosinophilic cystitis and allergy to mitomycin-C.
Topics: Aged; Antineoplastic Agents; Carcinoma, Transitional Cell; Cystitis; Eosinophilia; Female; Humans; M | 1990 |
Dermatitis due to intravesical mitomycin C: a delayed-type hypersensitivity reaction?
Topics: Administration, Intravesical; Aged; Aged, 80 and over; Alkylating Agents; Antigen-Presenting Cells; | 1990 |
Effect of mitomycin C and doxorubicin instillation on carcinoma in situ of the urinary bladder. A Finnish multicenter study.
Topics: Administration, Topical; Adult; Aged; Buffers; Carcinoma in Situ; Cystitis; Doxorubicin; Female; Hum | 1986 |
Allergy to mitomycin C complicating topical administration for urothelial cancer.
Topics: Administration, Intravesical; Aged; Carcinoma, Transitional Cell; Cystitis; Drug Hypersensitivity; E | 1987 |
Intravesical mitomycin C therapy for superficial bladder cancer. Report of a multicentre phase II study.
Topics: Carcinoma, Transitional Cell; Cystitis; Drug Evaluation; Humans; Mitomycin; Mitomycins; Skin Disease | 1985 |
[Sequential intravesical chemotherapy with mitomycin C and adriamycin for superficial bladder tumor (preliminary report)].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cystitis; Doxorubicin; Female; Humans; | 1985 |